Psychedelics like psilocybin, DMT, and LSD are increasingly
welcomed in behavioral and psychiatric research, with
implications that extend well beyond neuroscience. This
webinar will delve into efforts to transform anecdotal evidence
into supported medical interventions through systematic
research and controlled clinical trials.
David Nutt, DM, FRCP, FRCPSYCH, FSB, FMEDSCI
Professor, Neuropsychopharmacology Unit
Centre for Psychiatry
Imperial College London
Psychopharmacology: From Principle to Practice.
An introduction to Drug Science’s Medical Psychedelics Working Group.
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.